Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
- 1 July 1999
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 34 (1), 144-150
- https://doi.org/10.1161/01.hyp.34.1.144
Abstract
Abstract —To determine whether pretreatment and/or in-treatment serum uric acid (SUA) is independently and specifically associated with cardiovascular events in hypertensive patients, we examined the 20-year experience of 7978 mild-to-moderate hypertensive participants in a systematic worksite treatment program. Clinical evaluation and treatment were protocol-directed. SUA was measured at entry and annually thereafter. Subjects were stratified according to gender-specific quartile of baseline SUA. Blood pressures at entry and in-treatment were, respectively, 152.5/95.6 and 138.9/85.4 mm Hg. SUA was normally distributed with a mean of 0.399±0.0893 and 0.321±0.0833 mmol/L for men and women, respectively. Subjects with highest SUA were heavier, had greater evidence of cardiovascular disease (CVD), higher systolic blood pressure, higher creatinine, more frequent diuretic use, and lower prevalence of diabetes. During an average follow-up of 6.6 years (52 751 patient-years), 548 CVD events (183 mortal) and 116 non-CVD events occurred. In bivariate analysis, the association of SUA to CVD was more robust in nonwhites than whites and in patients at low versus high CVD risk. In multivariate analysis, CVD incidence was significantly associated with SUA with a hazard ratio of 1.22 (95% confidence interval 1.11 to 1.35), controlling for other known cardiovascular risk factors, including serum creatinine, body mass index, and diuretic use. Despite blood pressure control, SUA levels increased during treatment and were significantly and directly associated with CVD events, independently of diuretic use and other cardiovascular risk factors.Keywords
This publication has 24 references indexed in Scilit:
- Relation of components of insulin resistance syndrome to coronary disease riskCurrent Opinion in Lipidology, 1994
- Towards the physiological function of uric acidFree Radical Biology & Medicine, 1993
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Mortality and treated blood pressure in patients of the European Working Party on High Blood Pressure in the ElderlyAmerican Journal Of Medicine, 1991
- The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly TrialAmerican Journal Of Medicine, 1991
- Evaluation of Renal Handling of Uric Acid in Essential Hypertension: Hyperuricemia Related to Decreased Urate SecretionNephron, 1991
- Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose ToleranceNew England Journal of Medicine, 1989
- Serum Uric Acid in Renovascular Hypertension: Reduction Following Surgical CorrectionThe American Journal of the Medical Sciences, 1987
- Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.JCI Insight, 1985
- Hyperuricaemia Related to Treatment of HypertensionBMJ, 1960